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Abstract: 
Context: Medication errors are a significant source of iatrogenic morbidity and 
mortality in the hospital inpatient setting. The pediatric population is especially 
vulnerable to medication errors because of the need to dose medications by 
weight and their inability to control and understand their medical condition. 
There are currently few epidemiological studies regarding medication errors in the 
pediatric inpatient setting. 
Objectives: To determine 1) the relationship between certain error types and the 
pediatric age at which these errors occur, 2) the relationship between the time to 
discovering medication errors and the pediatric age at which these errors occur, ! 
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and 3) to integrate these findings into a model to determine if age is an 
independent predictor of clinical severity. 
Design: Quantitative analysis of database of self-reported medication errors 
spanning 2 years from February 2000 to May 2002 at the University ofNorth 
Carolina. 
Results: We reviewed 6247 medication error reports classified into one of 16 
error types. We discovered that certain error types involving incorrect IV /TPN 
solutions, incorrect IV /TPN rate, and IV incompatibility occurred in a 
significantly younger age population, and that other error types such as allergy I L 
due to medication and medications given at an incorrect time or frequency 
occurred in a significantly older age population. Younger patients on average 
experienced errors discovered during the same shift than older patients. Age was 
found to be an independent predictor of clinical severity in a limited regression 
model. 
Conclusions: Age is a significant predictor of medication errors regarding certain 
clinical error types, time to discovery, and clinical severity 
Introduction: 
After the Institute of Medicine published their report on medication errors 
in 1999 stating that medical errors kill some 44,000 to 98,000 people in U.S. 
hospitals each year, interest in this subject has increased dramatically as both 
patients and providers assess the impact on the quality ofhealth care.1•2 While 
much of the focus has been centered around the adult population, it may be 
surprising to discover that medication errors have also been recognized as an 
important cause of iatrogenic morbidity in the pediatric age group, and pediatrics 
ranked 6th across 16 medical specialties in the frequency of medication error-
related litigation. 3 Unfortunately, few studies have been published characterizing 
the nature of medication errors in the pediatric population despite data suggesting 
that the financial and clinical consequences of pediatric medication errors are 
more severe than those in the adult population.4 
Descriptive studies on pediatric errors have focused on the rates and types 
of errors in major medical centers. One study conducted in Boston found that 
overall rate of medication errors in the pediatric population was 55 per 100 
admissions and 10 additional potential adverse drug events per 100 admissions. 
Age stratification of these error rates further revealed that the rate of both errors 
and potential errors in neonates was substantially higher than the overall rate ( 62 
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and 20 per 100 admissions respectively) and that for neonates in the intensive care 
unit, the rates were even higher (91 and 46 per 100 admissions respectively).2 
Another study conducted in Glasgow, Scotland reported an overall error rate of 1 
per 662 admissions and 1 per 100 admissions for neonates in the intensive care 
't 4 urn. 
The systemic nature of medication errors has been well characterized. 5•6 
Many hospitals recognize the potential for medication error and seek to create 
measures to prevent errors from occurring. Indeed, quality improvement studies 
of medication errors have primarily focused on the systemic nature of errors, and 
in particular the fallacy of blaming individuals for medication errorsY In 
particular, the introduction of computer order entry, mandating double checking 
of all orders, including a pharmacist on work rounds, and improving medication 
error reporting have all been suggested to reduce medication errors on the wards 
and in the ICU.5 One recent study attempted to characterize public and provider 
perceptions on medication errors and how such problems could be better solved. 
The authors found that although the public were varied on their beliefs of 
proposals that would be effective, a majority of practicing physicians only viewed 
two proposals as very effective - requiring hospitals to develop systems for 
preventing medical errors, and increasing the number of nurses in hospitals. 8 
Indeed, Vlilson et al report L~at deficiencies in hospital and departmental policy 
contribute significantly to occurrences of medication errors - examples include 
lack offail-safe mechanisms and complicated antibiotic prophylaxis policies. 3 
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The descriptive studies carried out by Kaushal et al suggest that 
improvements in medication ordering and processing may reduce the risks of 
errors. As mentioned earlier, they note that computer order entry and dedicated 
clinical pharmacists in intensive care units would help to reduce medication errors 
that involve written and verbal transcription, and weight-based dosing 
calculations.2 Cox et al note in particular that improved error reporting has 
increased the epidemiology of medication errors such as frequency of error types, 
and has guided the systemic changes needed to reduce error frequency.5 
Unfortunately, pediatric patients pose a greater challenge regarding the 
epidemiology and prevention of medication errors than do adult patients. 2 
Children require weight based dosing for virtually all drugs and many 
medications must also be diluted prior to administration. Younger children 
especially also do not have the capacity to advise the health care team of any 
potential mistakes in administering medications and do not appreciate the 
responsibilities of taking medications that adults do. Finally, children possess 
more limited internal reserves, increasing the chance that medication errors have 
more severe clinical consequences. 
A pilot study investigating the relationship between clinical severity, 
patient age, and ICU/non-ICU status was conducted over the summer of2002 at 
UNC hospitals. Prelitnina..-j results obtained after analysis have suggested that 
clinical severity in the pediatric age group is related to ICU status, but not to 
patient age after adjustment for various factors including error type, time to 
discovery, system components, and medication type.9 As noted earlier, Kaushal 
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et al have suggested that neonates experience more frequent and severe clinical 
errors than do other pediatric patients for a variety of reasons, but there have been L 
few studies which have examined more closely the correlation between patient 
age and medication errors.2 
Our study seeks to examine to the relationship between the age of 
pediatric patients to whom medication errors occur and different variables of 
medication errors such as error type, time to discovery of the variance, and 
severity. In particular, we seek to answer the following questions: 1) Does a 
relationship exist between the age of the patient and the error type; 2) Does a 
relationship exist between the age of the patient and time it takes to discover the 
error; and 3) Does an independent relationship exist between the age of the patient 
and the severity of the error corrected for confounding variables? We hypothesize 
that the age of the patient predisposes to certain types of medication error and 
possible increased clinical severity that would merit further studies into the 
systemic nature behind these errors. 
Methods: 
This study reviewed over 6,200 pediatric records stored in a database at 
the University of North Carolina Hospitals, and was a joint project involving the 
School of Pharmacy, the School of Medicine (division of Emergency Medicine) ~-
a11d the School of Public Health. This hospital is a major teaching hospital i11 the 
United States and is one of the leading health care centers in the state of North 
Carolina. In February 2000, UNC hospital began a voluntary medication error 
reporting system on all the pediatric floors covering most of the pediatric services. 
Reports were collected on standardized forms and all reports were subsequently 
sent to the School of Pharmacy's Drug Information Center. Several experienced 
pharmacists then reviewed and compiled the data and entered it into a database, 
characterizing the data by different criteria including severity level of outcomes, 
error type, time to discovery of the error, attributable causes, class of medication, 
and provider type. Discrepancies in classification were resolved by discussion 
amongst the pharmacy review board. By May of2002, 6,247 reports had been 
collected, and all reports were used in the following analysis. (See Figure 1 for a 
copy of the UNC Medication Safety Report). 
The "error types" variable was originally classified into 16 independent 
categories, including an "other" category. These variables enter the model as 16 
dummy variables. Similarly, the ''time to discovery" variable was classified into 
5 independent time periods: (same shift, within 24 hours, 24-48 hours, 48-72 
hours, and 72+ hours). The latter two variables were collapsed due to infrequent 
observations. 
Statistical Methods: 
The purpose of this study was two-fold; first, to determine if a relationship 
exists between patient age, the type of error that could be incurred, and the time to 
variance discovery; and second, to determine if age is an independent predictor of 
severity adjusted for error type and time to va;iance discovery. Patient age was 
characterized in two ways. As a linear, continuous variable, we log transformed 
age to reduce the skew of the data. Student t-test analysis was then performed to 
determine the mean age in months of each particular error type and time to 
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variance discovery. We also analyzed age as a categorical variable divided into 5 
age groupings: 0-1 months, 2-12 months, 1-5 years, 6-12 years, and 13 or more 
years. (See table 5 for age and number breakdown). A Pearson chi-squared 
analysis was then performed to determine relationships between age, error type, 
and time to variance discovery for all age groups and all error types and times to 
discovery. Only those found to be significant (p< 0.05) were reported. 
The dependent variable in our ordered logistic regression was severity 
level- an ordered, categorical variable indicating the severity of outcome caused 
by a medication error. The classification of severity level on a 7 point scale 
(range 0-6) is similar to the one described by Sclmeider and Hartwig, and is ! j 
i defined as follows: 10 Level 0: No actual incident. Potential errors were classified in this category. 
Levell: Incident did not result in patient harm. 
Level 2: Incident resulted in the need for increased patient monitoring, but no 
change in vital signs and no patient harm. 
Level 3: Incident resulted in the need for increased patient monitoring, with a 
change in vital signs, but no ultimate patient harm, or any occurrence that resulted 
in the need for increased patient monitoring. 
Level4: Incident resulted in the need for treatment with another drug or 
increased length of stay. 
Level 5: Incident resulted in permanent patient harm. 
Level 6: Incident resulted in death. 
As the dependent variable to be analyzed is an ordinal variable, the correct 
model would be an ordered logistic regression. Standard beta-coefficients were 
used in reporting the results of the logistic regression. 
The statistical software package used for the data analysis was Stata 
version 7.0. 
Results: 
Descriptive Analysis 
As mentioned previously, a total of 6,247 errors were reported over a 31 
month period, of which 5,966 could be divided into one of 15 categories of 
possible error types. 281 records did not specify an error type and thus have been 
omitted from the analysis. Table I illustrates the breakdown of error type and 
mean age (in months) of patients for which these error types occurred. The most 
frequent types of errors were those that involved dosing: 1,255 errors (21.0%) of 
all reported errors by error type were due to the administration of an incorrect 
dose, followed by 745 (12.5%) errors where the dose was not available, and 716 
(12.0%) errors where the medication was given at the incorrect time or with 
incorrect frequency. The least frequent types of errors were those involving IV 
incompatibility (0.1 %), allergy to medication (0.3%), and expired drugs (0.3%). 
There were also 5,532 reports that documented the time to discovery of 
the medication errors (see Table 2). The vast majority of errors were discovered 
within the same shift (12 hours) as when the error occurred, and over 95% of 
errors were discovered within a 24 hour period. 
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Bivariate Quantitative Analysis 
Table 3 illustrates the results of the student's t-test comparing the mean 
ages of patients at which the different error types occurred. The results indicate 
that certain types of variances (incorrect IV /TPN solution, incorrect IV /TPN rate, 
IV incompatibility) occur with a significantly younger patient population than do 
other types of variances. The results also indicate that older children are 
susceptible to certain types of variances over others, including no order for 
medication and allergy due to medication. 
Table 4 illustrates the results of the student's t-test comparing the mean 
ages of patients at which the time to discovery of the error types occurred. The I 
L 
~ results indicate that errors involving younger children are discovered earlier than errors involving older children. The mean age of patients at which the medication 
error was discovered during the same shift was significantly younger than those 
not discovered during the same shift. This trend was then reversed over the next 
12 hours, such that errors involving older children were discovered between 12 L ~-
and 24 hours compared to errors involving younger children. Interestingly, after 
24 hours there did not appear to be a significant relationship between age and time 
to discovery. 
Table 5 illustrates the patient population subdivided into 5 age categories: 
0-1 months, 2-12 months, 1-5 years, 6-12 years, and greater tha;1 13 years. These 
groups were classified based on standard age groupings of pediatric patients as 
noted by Medline search. Each strata consists of approximately 20% of the ~-
patients in the study. 
Table 6 illustrates the results of a chi-squared analysis comparing the 
likelihood of patients in a certain age bracket experiencing an error involving 
incorrect IV/TPN solution. The frequency of errors in the youngest age group 
(the neonates) involving an incorrect IV/TPN solution is higher (18%) than the 
frequency ofiV/TPN solution errors of the other age groups (3-6%). 
Interestingly, infants (2-12 months age group) also experience a significantly 
higher frequency of errors relative to the two eldest age brackets (p<0.05, data not 
shown). It appears that the frequency of error due to incorrect IV/TPN solution 
increases as age increases. 
Table 7 illustrates the results of a chi-squared analysis comparing the 
likelihood of patients in a certain age bracket experiencing medication errors that 
involved an incorrect time or frequency of the dose. The results suggest that 
children in the oldest age bracket experience more frequent errors involving 
incorrect time/frequency (16%) than do children in younger age brackets (10-
12%). 
Table 8 illustrates the results of a chi-squared analysis comparing the 
likelihood of patients in a certain age bracket experiencing medication errors that 
involved an incorrect IV/TPN rate. Similar to errors that involve incorrect 
IV /TPN solutions, the youngest age bracket experience a significantly higher 
frequency of errors (3.5%) versus the older age groups (l-2%). 
Table 9 illustrates the results of a chi-squared analysis comparing the 
likelihood of patients in a certain age bracket experiencing medication errors 
where the dosage was not available or missing. Infants (age 2-12 months) 
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uniquely experience more frequent errors due to this error type (16%) than do 
other age groups (10-13%). 
Table 10 illustrates the results of a chi-squared analysis comparing the 
likelihood of patients in a certain age bracket experiencing medication errors that 
involved administering an incorrect dose. Interestingly, toddlers (age 1-5 years) 
experience the highest frequency of errors (27%) relative to other age groups ( 15-
22%), and the oldest children significantly experience the lowest frequency of 
errors (15%) relative to the other age groups (19-27%). 
Table 11 illustrates the results of a chi-squared analysis comparing the 
likelihood of patients in a certain age bracket experiencing medication errors that ] 
involved allergy due to medication. Although the frequency of error is rare I 
overall, there appears to be an overall trend suggesting that errors of this nature r 
are more frequent as the age of the patient increases. The statistical significance 
of this finding is strongest when comparing the frequency of errors in the 
youngest patients and the oldest patients, and is less significant when comparing 
age groups in the middle. 
Ordered Logistic Regression Model: 
The results of the ordered logistic regression are documented in Table 12. 
' 
An ordered logistic regression analyzing only the effects of error type and time to L 
discovery illustrates that a negative relationship between age and severity of error 
exists, and further that certain error types significantly influence the severity of 
the error in the context of age. In particular, error types that appeared to increase 
the clinical severity include incorrect IV/TPN rate, administering extra doses of 
medication, giving patients medication that has expired, failing to give patients 
medication at the proper time, and medication/patient IV incompatibility. These 
results suggest that despite the confounding relationships between age, error type, 
and time to variance discovery, age remains an important predictor of clinical 
severity. 
Discussion: 
As reported by Kaushal et al, it is well known that medication errors are 
common in the inpatient pediatric setting, and that errors occur most often and are 
most severe amongst the very youngest pediatric patients, the oldest pediatric 
patients, and those in intensive care units.2 However, few studies have attempted 
to demonstrate a relationship between age and specific error types. The results of 
this study indicate that children at certain age groups are more prone to particular 
error types than children of other ages, and that these trends seem to hold true 
when age is classified into pediatric age groupings. The results also broadly 
suggest that medication errors seem to be discovered sooner with the youngest 
patients across all error types, a finding that has significance when determining 
the systemic components behind medication errors. 
It has been reported in the pediatric literature that the most common error 
types among pediatric patients were errors involving the intravenous route, dosing 
errors, errors of omission, and unauthorized drug errors.2'10 Indeed, we have 
found in our study that these types of errors are among the highest reported at 
UNC hospitals. We were able to expand on these findings by confirming that 
errors involving incorrect dosing, IV medications, and errors of omission were 
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among the leading medication errors reported in our database. Further, we 
suggest that there is a significant age difference at which errors involving IV 
medications occur. The mean age for patients who received an incorrect IV 
solution was just over 4 months, the mean age for patients who received an IV 
medication at an incorrect rate was approximately 7 months, and the mean age for 
patients who had IV incompatibility was 3 months. This can be compared to an 
average age of 18-20 months for patients not experiencing the error, and an 
average age of 19.5 months for all patients in the database. 
It is reasonable to infer that medication errors involving intravenous 
routes, rates and compatibility would affect younger patients more frequently than 
older patients because they are dosed primarily on weight and are generally I 
F 
' 
reserved only for the sickest patients in the intensive care units.2•11 Because 
neonatal weights change rapidly and other co-morbidities are occurring 
concomitantly, appropriate dosing is made more difficult given the circumstances. 
Interestingly, we found that errors involving an incorrect IV solution, as opposed 
to an incorrect IV rate or incorrect IV incompatibility, did not appear to affect the 
clinical severity when corrected for age. This is unexpected because one would 
expect medication errors in critically ill neonates to have more severe outcomes 
given their limited ability to physiologically buffer errors compared to healthy t-
neonates or older children. 2 It has also been reported tJmt I'/ medications present 
a special challenge for nurses and pharmacists because they are often not supplied 
in dosages suitable for the very young and that IV pumps are often not specific L 
enough to dose fluids to exact specifications often required for neonates.2 
Especially in the intensive care units where nursing supervision is already taxed, 
the extra attention needed to accurately dose IV medicines may not be available, 
increasing the rate and frequency of errors.12 Further studies are needed to 
validate this theory. 
When IV medication errors were stratified by age group, the results 
obtained are very similar to those obtained by the linear model. We discovered 
that the two youngest age brackets experienced a higher percentage of errors 
involving IV medications relative to older age brackets and to each other, and the 
youngest age bracket experienced a higher percentage of errors due to incorrect 
IV rates relative to older age brackets. Indeed, the results of this analysis suggest 
a linear relationship between age and errors involving IV /TPN solutions that one 
could reason is caused by the difficulty of weight based dosing at younger ages, 
although further studies would be needed to corroborate this idea. The alternative 
way of grouping the data confirms the results discussed earlier- that IV 
medications present a unique challenge to the very young. 
The incidence of medication errors as a consequence of allergic responses 
has not been well documented in the literature, and has not been implicated as a 
major source of error compared to other error types. Although there were only 16 
reported cases of medication errors due to medication allergies, we found that 
medication errors due to allergic responses more frequently affected older 
children than younger children. The differences in mean age for this error type 
was both striking and surprising. It is possible that the immune systems of 
younger children are not as well developed as those of older children, thus 
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enhancing the severity and manifestation of allergic reactions in older children. It 
is also feasible that older children get asked more often about medication allergies L 
than do infants and toddlers, such that allergic reactions developed in younger 
kids are not classified as "errors". Interestingly, other published data on 
medication errors relating to allergic responses have also detailed the increased 
morbidity of medication errors related to allergy in children.13 
Other error types that have received much study in the pediatric 
population recently are so-called ''ten-fold errors"- named for the propensity of 
pediatric dosing errors to be made in multiples often. 14 Indeed, a recent review 
of ten-fold medication dosing errors revealed that tenfold medication errors are 
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common and associated with identifiable risk factors such as inexperienced 
pediatric residents, and verbal and transcripted order entry systems. 5•14 Our study 
detected over 1200 cases of dosing errors, which although not further classified 
into sub-types, was the largest grouping of error types reported. It has been 
postulated that dosing errors are especially common with pediatric patients i F 
because of their need to have medication dose adjusted for weight, and that 
residents (who are the physicians most likely to prescribe medication in the 
inpatient setting) are also the least experienced physicians at calculating 
medication doses. 14 Another factor contributing to ten-fold errors is the 
medication involved and how it is normally dosed. Lesar describes levothyroxine 
as a particular drug that causes problems in dosing because it is typically dosed in 
microgram units instead of the more common milligram units. It would be 
interesting to further study the data to determine whether ten-fold dosing played a 
large role in the large number of medication errors of this error type in our study, 
and whether a particular drug class contributes to a disproportionate share of such 
errors. In an unpublished study conducted at UNC using the same pediatric 
database, antibiotics and electrolytes were the drug classes where errors were 
most likely to occur; however, there did not seem to be a relationship between 
errors involving these medications and the mean age of the patient.9 Further study 
is needed to validate this relationship. 
An interesting observation generated from our results was the difference in 
age for patients who experienced medication errors involving incorrect 
time/frequency. Previous data has suggested that patients in ICU settings 
experience a greater number of errors than patients in non-ICU settings, and 
younger patients in the NICU experience the highest rates and severity of errors 
overall.2 Although no studies have been performed to further analyze this trend, it 
has been suggested that closer monitoring by nurses and physicians in the ICU 
could explain why potential errors are caught in younger patients before they are 
made. This especially pertains to errors involving incorrect time/frequency 
because we postulate that many of these errors occur on the distribution level 
(nurses are too busy at the time the dose is due to administer the drug), which is 
more significant on the floors where more patients are involved, than in the ICU 
where each nurses cares for only two or three patients at most. This relationship 
holds even when age is analyzed by pediatric grouping. The implications of this 
finding are significant when evaluating systems based causes for error, and merit 
further study. 
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The majority of errors documented in this study were discovered within 
the same shift as when they occurred. We found that there was a significant age 
difference in terms of when errors were discovered, with errors involving younger 
patients discovered sooner than errors involving older patients. Reasons for this 
echo those outlined above- that the youngest patients are also the likeliest to be 
in the intensive care unit and thus most likely to receive high intensity monitoring. 
The results also suggest a linear relationship between the time to discovery of the 
error and the age of the patient, probably for the reasons outlined above. It has 
L 
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r been reported that the longer the elapsed time to discovery of the error, the more 
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severe the clinical outcome.9 This finding is significant because it demonstrates 
L 
I the necessity of discovering errors quickly to prevent worse clinical outcomes, and suggests that changes in monitoring are the keys to decrease the time to error 
detection. 
The results of this study as discussed thus far seem to indicate that a 
relationship between patient age, error type, and time to variance discovery exists 
for certain error types, especially those involving N medications. A previous 
study using the same study database demonstrates that no significant relationship 
exists between age and clinical severity of outcome when many correlated 
variables, including error type, time to variance discovery, medication type, L 
processing errors, a.11d errors involving system failures are included. 9 However, in 
a more limited analysis of the data, our regression shows that age is a significant 
predictor of clinical severity when controlled for potential confounders such as 
error type and time to error discovery. This result is interesting because it 
demonstrates that despite confounding variables, younger patients have clinically 
more severe outcomes when experiencing errors than do older patients. Larger 
studies and more extensive logistic regressions have generated mixed results 
when attempting to determine relationships between age and clinical severity of 
medical errors. In a previous study analyzing the relationship between clinical 
severity, age, and medication type, several high alert medications were shown to 
produce more clinically adverse outcomes in infants and children under two years 
of age. 15 However, an unpublished regression model taking into account 
medication type studied at UNC failed to demonstrate a clear relationship 
between age and clinical severity when medication type was included as a 
confounding variable. 9 It would be interesting to investigate whether a I 
f relationship exists between certain drug classes and the severity caused by an 
omitted or extra dose, both of which would be expected to cause a worse clinical 
outcome with potent medications such as antibiotics or chemotherapeutic agents. 
Further studies on this interesting question are needed for more definitive results. 
There are many limitations to our data analysis that should be taken into 
consideration when interpreting the results from this study. First, the data in the 
UNC medication safety database is generated solely from self-reported errors, 
such that an uncharacterized selection bias may be present. It has been reported L 
that the number of actual errors exceeds the number of self-reported errors by up 
to ten-fold. Self reporting is also influenced by multiple factors, including the 
institutional consequences of accountability, the obviousness of the error, and the 
availability of time the reporter has to report the error. For example, nurses 
working in the ICU would appear to be under greater time restrictions and be less 
likely to be able to file medication variance reports than nurses on a non-acute 
pediatric floor. 
Self reported errors also tend to be more subjective in nature than 
objectively observed error reporting. Although the pharmacy review board 
attempted to consistently characterize each variance as objectively as possible, the 
review process was largely dependent on subjective reporting. Further, reported 
errors were not cross-checked with medical records to compare reports. 
Another caveat to the interpretation of the results is the categorization of 
many errors into the "other" error type, as self-reported by the reporter. This 
grouping originally was divided into 42 additional error types with minimal 
numbers of reports in each by the review committee. However, it was felt that the 
error types were not sufficiently similar in each group to accurately reflect the 
process occurring, and at the time of this writing, the review committee is seeking 
to find another way of characterizing these reports into the analysis. This 
category is especially important because, as shown in table 3, there is a significant 
age difference in patients who experience these types of errors. Further 
characterization of these errors would therefore be useful in this analysis. 
Another potential problem in this study is omitted variable bias. The time 
to error detection in an inpatient floor or intensive care setting depends heavily on 
staffing-related variables which are not characterized in our study. We have 
proposed in our discussion that ICU settings have more intensive monitoring of 
patients and thus earlier times of error detection, but we have not taken into 
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consideration potential confounding factors such as staf:fi'patient ratio, the average 
number of hours worked by the staff, and the average working experience of the 
staff. 
Lastly, the data is based on a medication variance reporting system from a single 
teaching hospital over a 2-year period with its own unique culture, and the results 
may not be generalizable to other medical practice environments. 
Conclusions: 
Our study examined the relationships in the pediatric population between 
age and error type, age and the time to variance discovery of these errors, and age 
and overall clinical severity of errors. We first determined that specific error 
types involving IV medications, routes, and dosing were significantly more likely 
to occur in younger patients than in older patients, thus suggesting that certain 
error types occur more frequently at a certain age. We also discovered that 
medication errors were more likely to be discovered during the same shift for 
younger patients than for older patients, and a general trend existed where older 
patients had their errors discovered later on average. This suggests that the age of 
the patient significantly influences the time to discovery of the medication error. 
Finally, we determined through a limited regression model that younger age was 
found to be a significant predictor of clinical severity independent of error type 
and time to variance discovery. We hope these findings will contribute to 
understanding the systemic causes of medication errors by suggesting that age is a 
significant variable when taking into account the nature of medication errors. 
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Table Legend 
Table 1: Reported Number of Error Types and Percentages. 
Table 2: Reported Number of Errors Categorized by Time to Discovery 
Table 3: Results of at-test analysis determining the relationship between the 
mean age of patients and error types. 
Table 4: Results of at-test analysis documenting the relationship between the 
mean age of patients and time to medication error discovery. 
Table 5: Number of patients per age group in the patient database. Age 
groupings are consistent with the pediatric literature. 
Table 6: Frequency (in percent) of errors involving incorrect IV/TPN solutions 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
Table 7: Frequency (in percent) of errors involving incorrect time or frequency 
of dose distributed by age group. P-values reflect a comparison to the age group 
listed at the top of the table. 
Table 8: Frequency (in percent) of errors involving incorrect IV/TPN rate 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
Table 9: Frequency (in percent) of errors involving an unavailable dose 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
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Table 10: Frequency (in percent) of errors involving an incorrect dose 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
Table 11: Frequency (in percent) of errors involving an allergy to medication 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
Table 12: Ordered logistic regression with severity as the dependent variable and 
age, specific error types, and time to variance discovery as the independent 
variables. For the error type variables, the incorrect dose was used as the referent 
group, and for the time to variance discovery variables, same shift discovery was 
used as the referent group. 
Table 1: 
L 
Error Type Number Percent f t-
Incorrect Patient 83 1.4 
Incorrect Route 97 1.6 
Incorrect N /TPN 432 I Solution 7.2 No Order for Medication 241 4.0 p 
Incorrect 716 
Time/Frequency 12.0 
Incorrect Dosage Form 106 1.8 
Incorrect N ITPN rate 103 1.7 
Allergy due to 16 
Medication 0.3 L 
Incorrect Dose 1255 
[--
21.0 
Extra Dose 43 0.7 
Expired Drug 20 0.3 
Incorrect Drug 177 3.0 
Omission/Not Given 357 6.0 
N Incompatibility 7 0.1 
Dose Not Available 745 12.5 ~ 
Other 1568 26.3 
Total 5966 
Table 1: Reported Number of Error Types and Percentages. 
Table 2: 
Time to Discovery 
Same Shift 
Within 24 hours 
24-48 Hours 
Morethan48 
Hours 
Total 
Number 
3421 
1868 
142 
101 
5532 
Percent 
61.8 
33.8 
2.57 
1.83 
Table 2: Reported Number of Errors Categorized by Time to Discovery 
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Table 3: 
Error Type Number Mean Mean t- P-value 
Age of Age of statistic 
patients patients 
with without 
reported reported 
variance variance 
Incorrect Patient 83 15.57 18.3 0.7265 0.4676 
Incorrect Route 97 19.44 18.2 0.3269 0.7437 
Incorrect IV /TPN 432 4.27 20.26 15.23 < 0.001 
Solution 
No Order for 241 21.23 18.1 -1.236 0.2166 
Medication 
Incorrect 716 23.13 17.63 -3.4775 0.0005 
Time/Frequency 
Incorrect Dosage Form 106 22.44 18.15 -1.1037 0.2698 
Incorrect IV /TPN rate 103 6.89 18.52 4.8842 < 0.001 
Allergy due to 16 95.58 18.13 -3.4623 0.0005 
Medication 
Incorrect Dose 1255 18.66 18.1 -0.4857 0.6272 
Extra Dose 43 11.05 18.28 1.6428 0.1005 
Expired Drug 20 19.53 18.21 -0.1582 0.8743 
Incorrect Drug 177 22.02 18.11 -1.304 0.1923 
Drug Omission/Not 357 21.88 18 -1.8186 0.069 
Given 
IV Incompatibility 7 2.93 18.25 2.249 0.0245 
Dose Not Available 745 19.12 18.09 -0.7203 0.4714 
Other 1568 22.05 17.01 -4.4889 < 0.001 
Total 5966 
Mean Age 19.5 
months 
Table 3: Results of at-test analysis determining the relationship between the 
mean age of patients and error types. 
~-
L 
~ 
I 
r 
~ 
' L 
l 
Table4: 
Error Type Number Mean Mean t- P-value 
Yes No statistic 
Same Shift 3421 16.66 19.71 3.0771 0.0021 
Within24 1868 19.58 16.91 -2.6084 0.0091 
hours 
24-48 Hours 142 23.23 17.64 -1.6448 0.1001 
Morethan48 101 17.19 17.77 -0.0047 0.9962 
Hours 
Total 5532 
Table 4: Results of at-test analysis documenting the relationship between the 
mean age of patients and time to medication error discovery. 
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Table 5: 
Age Number Percent 
0-1 months 1240 20.2 
2-12 months 1365 22.2 
1-5 years 1128 18.4 
6-12 years 1217 19.8 
13 +years 1192 19.4 
Total 6142 
Table 5: Number of patients per age group in the patient database. Age 
groupings are consistent with the pediatric literature. 
Table 6: 
Mean Yes 
AgeGrOU.(! {%} .[!-value 
0-1 months 18.8 
2-12 months 5.64 0.000 
1-5 years 4.43 0.000 
6-12 years 3.20 0.000 
13+ years 3.02 0.000 
Table 6: Frequency (in percent) of errors involving incorrect IV/TPN solutions 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
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Table 7: 
Mean Yes 
Age Group (%) p-value 
13+ years 16.44 
0-1 months 10.73 0.000 
2-12 months 10.55 0.000 
1-5 years 10.64 0.000 
6-12 years 12.24 0.003 
Table 7: Frequency (in percent) of errors involving incorrect time or frequency 
of dose distributed by age group. P-values reflect a comparison to the age group 
listed at the top of the table. 
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Table 8: 
Mean Yes 
Age Group (%) p-value 
0-1 months 3.47 
2-12 months 1.68 0.004 
1-5 years 1.15 0.000 
6-12 years 0.9 0.000 
13+ years 1.34 0.001 
Table 8: Frequency (in percent) of errors involving incorrect IV/TPN rate 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
Table9: 
Mean Yes 
Age Group (%) p-value 
2-12 months 15.9 
0-1 months 10.08 0.000 
1-5 years 9.84 0.000 
6-12 years 13.06 0.042 
13+ years 12.08 0.006 
Table 9: Frequency (in percent) of errors involving an unavailable dose 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
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Table 10: 
Mean Yes 
Age Group (%) p-value 
l-5 years 26.86 
0-1 months 19.84 0.000 
2-12 months 19.56 0.000 
6-12 years 22.27 0.010 
13+ years 15.6 0.000 
13+years 15.6 
0-1 months 19.84 0.006 
2-12 months 19.56 0.009 
1-5 years 26.86 0.000 
6-12 years 22.27 0.000 
Table 10: Frequency (in percent) of errors involving an incorrect dose 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
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Table 11: 
AgeGrou~ Mean Yes{%} ~-value 
1-2 months 0.00 
2-12 months 0.07 0.340 
1-5 years 0.27 0.069 
6-12 years 0.33 0.043 
13+ years 0.67 0.004 
AgeGrou~ Mean Yes(%) ~-value 
13+ years 0.67 
1-2 months 0.00 0.004 
2-12 months 0.07 0.011 
1-5 years 0.27 0.156 
6-12 years 0.33 >0.20 
Table 11: Frequency (in percent) of errors involving an allergy to medication 
distributed by age group. P-values reflect a comparison to the age group listed at 
the top of the table. 
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Figure Legend 
Figure 1: Medication Error form used to generate database (front page) 
Figure 2: Medication Error form used to generate database (back page) 
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o!VaMnc:e 
a Incorrect patient 
o Incorrect route 
a Incorrect IV/TPN solution 
o No order for medication 
o Written '--
CJVerbal " 
o Routine .._ 
oStat -' 
CJ First dose -
oScheduled '-..... 
CJPRN / 
o One time only 
\ L 
UNC 
HEALTH CARE 
Patient Stamp Plate (lf_stainp plate Is not available, please fill in pailent 
name. medical record number, and date of b!rth} 
nme: Patient Location: 
o Incorrect timelfreq. 
o lncorrection dosage form 
o Incorrect IV/TPN rate 
due to mecication 
o Incorrect dose 
CJ Extra dosS 
o Expired drug 
o Incorrect drug 
Service: 
o Omission/not given 
CJ IV incompatibility 
CJ Dose not available 
c:::J Other. 
CJ Tube station 
oUnknown 
CJ7 or more 
administration 
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Figure 1: Medication Error form used to generate database (front page) 
Qofinl!!ppfi qf !Ayala 
Level 0: No actual Incident Classify potentla1 errors here. 
Level t: Incident did not result In pa1lent harm. 
Level2! Incident ~ In the need for Jncreased patient monitoring, but no change in vital signs and no patient harm. 
,_ 
Level3: Incident resul!!ed In the need for lncreasecl patient monitoring, with a change In vital signs, bUI no uiUmate patient harm, or any occurrence ttiat 
resultadbl the need for Increased patient monitoring. 
Level4: lncidenl1aSultad in the need for treatment with another drug or increasecll&ngth of stay. 
l..eve\5: lncldentiesufted In pennanent patient harm. 
L.evel 6' Incident res!Jted In death 
INFORMATION BELOW TO BE cOMPLETED BY MEPICATION SAFETY TEAM 
Medication Variance Follow-Up 
This tonn Is not part of the medical record. Quality Assurance/Peer Review Information 
Confidential Self lnswance Program Information Phannacy and Therapeutics Advlso!y Committee; 
Atb1butabht a Prescribing o Computer order entry o Delivery 
causes: o Order processing on unit , o Preparation a Administration 
o c;>n::ler processing in pharmacy o Dispensing . CJ p.linical moRitor!ng 
System ~ o Drug knowledge diSsemination CJ Transferllransitfon procedures 
faflures: ... a Dose and identity checking Cl Conflict resolution 
2.( " o Patient Information availability a Staffing and work assignments 
.,_ a O{der transcription CJ lntraservice communication 
~ "' Allergy defense c Patient education 
' cMedication o-1!acking o Computer systems/informatics 
7 clntetseMce commlllication o Clinical monitoring 
, c:: Device use o Feedback about medication occurences 
, CJ-oldosesand~ o Prep of IV admixture by non-phaJmacy personnel 
loc::J StandartiZallon of drug c:ls:lriJu6on cOthSr: ,, CJ- ofprocedlns 
SWnmory: 
INFORMATION BELOW TO BE COMPLETED BY PEER REVIEWER 
To complete this Section online go to www ynch uno edu/caj and click on the •Pharmacy Review Forms• link 
Or pleue l'lllwnto II 1' tlon Safety Team. Pharmacy Department. CBI:7800 Retum By: 
Do you agree with the designated severity index, attributable causes and systems failures? a Yes o No 
H no, please justify: 
r 
Conclusions/Recommendations: 
Peer reviewer: 
... -.•. 
· Reviewer's Title: Date: 
Reviewer's PhOne/Pager: 
Figure 2: Medication Error form used to generate database (back page) 
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